Physician profile
Oliver E Austria
NPI 1912359811
$797.66
in general payments reported to CMS, 2019-2025
10 companies · $304 in 2025
The $304 reported for 2025 was more than what 84% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.00 · 2020: $50.00 · 2021: $141 · 2022: $35.16 · 2023: $213 · 2024: $24.09 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $300 · Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $300.00 |
| Food and Beverage | $241.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $289.64 | 2025 | |
| Straumann USA LLC | $217.42 | 2022-2023 | |
| Implant Direct Sybron International LLC | $72.25 | 2021-2022 | |
| Centrix INC | $70.87 | 2021 | |
| Zimmer Biomet Holdings, INC. | $50.00 | 2020 | |
| Align Technology, INC. | $30.00 | 2019 | |
| Elevate Oral Care | $27.40 | 2023-2024 | Just Right 5000, Fluorimax Mint, Fluorimax 5000 |
| Geistlich Pharma, North America, INC. | $16.06 | 2021 | |
| Dentsply Sirona INC | $14.18 | 2025 | Suresmile |
| Ultradent Products INC | $9.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Austria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.